We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Intellectual Property

Intellectual Property Law360 provides breaking news and analysis on IP law. Coverage includes high-stakes cases involving patents, copyrights, trademarks, trade secrets, and other forms of IP, as well as policy developments and licensing deals.



Sign up for a 7-day FREE trial today!



Latest News in Intellectual Property

  • December 7, 2018

    DOJ Antitrust Head Redoing Patent Accord To Help IP Owners

    The head of the U.S. Department of Justice’s Antitrust Division on Friday delivered one of the sharpest examples yet of the division’s new emphasis on protecting patent holders by promising to rewrite an Obama-era policy on standard-essential patents and to crack down on standard-setting bodies that disrupt competition.

  • December 7, 2018

    Door Maker Wins Price Protections After $185M Verdict

    A North Carolina-based door part supplier will have to align its prices with fluctuating input costs and share that data with its buyer to comply with findings in a $185 million antitrust verdict, a Virginia federal judge ruled Friday.

  • December 7, 2018

    Fed. Circ. Revives Medical Device Co. Laerdal's ITC Case

    The Federal Circuit on Friday overturned a U.S. International Trade Commission decision refusing Laerdal Medical Corp.’s request for an import ban against companies accused of infringing its trade dress rights to medical devices, saying the ITC waited too long to take issue with Laerdal’s allegations.

  • December 7, 2018

    Fed. Circ. Reverses Ax Of Novartis Patent Due To 1995 Law

    The Federal Circuit on Friday reversed a lower court decision invalidating a Novartis AG patent on the cancer drugs Zortress and Afinitor, saying that a 1995 law changing the length of patent terms meant the doctrine of double-patenting did not apply in the case.

  • December 7, 2018

    J&J Can't Escape Retailers' Antitrust Suit Over Remicade

    Johnson & Johnson must face an antitrust suit accusing the drugmaker of foisting the brand drug Remicade on pharmacies and preventing them from carrying competing biosimilars, according to a Pennsylvania federal judge's ruling released Friday.

See more Intellectual Property news

Intellectual Property

Areas of Coverage

  • LITIGATION
  • Infringement suits over patents, copyrights, and trademarks
  • Patent Trial and Appeal Board disputes
  • Abbreviated New Drug Application (ANDA) litigation
  • Section 301 cases
  • Trade secrets disputes
  • Licensing and royalty fights
  • Right-of-publicity suits
  • Antitrust disputes involving IP issues
  • AGENCIES
  • U.S. Patent and Trademark Office
  • U.S. Copyright Office
  • U.S. International Trade Commission
  • World Intellectual Property Organization
  • POLICY & REGULATION
  • Patent reform legislation and related bills in Congress
  • Efforts to streamline international intellectual property law
  • ENFORCEMENT
  • Piracy and counterfeiting actions
  • International trade disputes involving IP issues
  • PROFILES
  • Personnel moves
  • Profiles of IP practices

Readership

  • Intellectual property lawyers at top law firms
  • Corporate counsel and compliance officers at Fortune 1000 companies
  • Executives and attorneys in the life sciences, technology, and other IP-focused industries
  • Information experts at law firms, agencies, and companies
  • Policymakers at federal and state agencies
  • Judges and court staff across the U.S.
  • Professors, students, and library staff at every accredited law school in the U.S.
  • Attorney and law firm marketing professionals